665 related articles for article (PubMed ID: 24332043)
21. [Fallopian tube: the dark face of pelvic carcinogenesis].
Watkin E; Devouassoux-Shisheboran M
Ann Pathol; 2011 Oct; 31(5):345-52. PubMed ID: 21982240
[TBL] [Abstract][Full Text] [Related]
22. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
23. Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.
Dietl J
Arch Gynecol Obstet; 2014 Feb; 289(2):241-6. PubMed ID: 24100801
[TBL] [Abstract][Full Text] [Related]
24. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
[TBL] [Abstract][Full Text] [Related]
25. The distal fallopian tube: a new model for pelvic serous carcinogenesis.
Crum CP; Drapkin R; Miron A; Ince TA; Muto M; Kindelberger DW; Lee Y
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):3-9. PubMed ID: 17218844
[TBL] [Abstract][Full Text] [Related]
26. STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis.
Mehra K; Mehrad M; Ning G; Drapkin R; McKeon FD; Xian W; Crum CP
Front Biosci (Elite Ed); 2011 Jan; 3(2):625-34. PubMed ID: 21196340
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations.
Otsuka I
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922503
[TBL] [Abstract][Full Text] [Related]
28. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
[TBL] [Abstract][Full Text] [Related]
29. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
[TBL] [Abstract][Full Text] [Related]
30. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Vang R; Shih IeM; Kurman RJ
Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
[TBL] [Abstract][Full Text] [Related]
31. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
32. Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.
Singh N; Faruqi A; Kommoss F; McCluggage WG; Trevisan G; Senz J; Lum A; Gilks CB; Anglesio M
Mod Pathol; 2018 Apr; 31(4):652-659. PubMed ID: 29148539
[TBL] [Abstract][Full Text] [Related]
33. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
Kindelberger DW; Lee Y; Miron A; Hirsch MS; Feltmate C; Medeiros F; Callahan MJ; Garner EO; Gordon RW; Birch C; Berkowitz RS; Muto MG; Crum CP
Am J Surg Pathol; 2007 Feb; 31(2):161-9. PubMed ID: 17255760
[TBL] [Abstract][Full Text] [Related]
34. Serous carcinogenesis in the fallopian tube: a descriptive classification.
Jarboe E; Folkins A; Nucci MR; Kindelberger D; Drapkin R; Miron A; Lee Y; Crum CP
Int J Gynecol Pathol; 2008 Jan; 27(1):1-9. PubMed ID: 18156967
[TBL] [Abstract][Full Text] [Related]
35. High grade serous ovarian carcinomas originate in the fallopian tube.
Labidi-Galy SI; Papp E; Hallberg D; Niknafs N; Adleff V; Noe M; Bhattacharya R; Novak M; Jones S; Phallen J; Hruban CA; Hirsch MS; Lin DI; Schwartz L; Maire CL; Tille JC; Bowden M; Ayhan A; Wood LD; Scharpf RB; Kurman R; Wang TL; Shih IM; Karchin R; Drapkin R; Velculescu VE
Nat Commun; 2017 Oct; 8(1):1093. PubMed ID: 29061967
[TBL] [Abstract][Full Text] [Related]
36. Precursors to pelvic serous carcinoma and their clinical implications.
Folkins AK; Jarboe EA; Roh MH; Crum CP
Gynecol Oncol; 2009 Jun; 113(3):391-6. PubMed ID: 19237187
[TBL] [Abstract][Full Text] [Related]
37. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
[TBL] [Abstract][Full Text] [Related]
38. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
Morrison JC; Blanco LZ; Vang R; Ronnett BM
Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
[TBL] [Abstract][Full Text] [Related]
40. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC
J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
